pHR_PGK_antiHer24D5-5_synNotch_Gal4VP64 Citations (2)

Originally described in: Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.
Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, Walker WJ, McNally KA, Lim WA Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29. PubMed Journal

---

Articles Citing pHR_PGK_antiHer24D5-5_synNotch_Gal4VP64

Articles
Synthetic Notch-Receptor-Mediated Transmission of a Transient Signal into Permanent Information via CRISPR/Cas9-Based Genome Editing. Sgodda M, Alfken S, Schambach A, Eggenschwiler R, Fidzinski P, Hummel M, Cantz T. Cells. 2020 Aug 20;9(9). pii: cells9091929. doi: 10.3390/cells9091929. PubMed
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification. Cortese M, Torchiaro E, D'Andrea A, Petti C, Invrea F, Franco L, Donini C, Leuci V, Leto SM, Vurchio V, Cottino F, Isella C, Arena S, Vigna E, Bertotti A, Trusolino L, Sangiolo D, Medico E. Mol Ther. 2024 Aug 7;32(8):2741-2761. doi: 10.1016/j.ymthe.2024.06.023. Epub 2024 Jun 17. PubMed

If you have published an article using this material, please email us at to have your article added to this page.